Profile_bird

Hey there! cafepharma is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving cafepharma's tweets.

Already using Twitter
from your phone? Click here.

cafepharma

  1. Nutrametrix Consultant US-Alabama: We are looking for select individuals that see the approaching, an... http://bit.ly/6zrrBt
  2. Merck cholesterol scrips drop as Niaspan rises- Fierce Pharma http://bit.ly/6EzIrp
  3. A Schizophrenic Move by Merck?- Motley Fool http://bit.ly/4KjPc9
  4. Still Enjoying Those Acquisitions, Pfizer?- Motley Fool http://bit.ly/7EIJnN
  5. Prospecting for Stocks: Novartis- Motley Fool http://bit.ly/66b4l5
  6. A Big Upgrade for Amylin Pharmaceuticals- Motley Fool 500 Internal Server Error 500 Internal Server Error nginx/0.7.42
  7. FDA grants full approval to J&J's HIV drug- Yahoo/AP http://bit.ly/4AVVcY
  8. Novartis terminates pact with Idera- Marketwatch http://bit.ly/7tec6S
  9. Roche CEO sees group outpacing market in 2009-paper- Reuters http://bit.ly/6s7CvH
  10. Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN- Yahoo http://bit.ly/7UAItS
  11. Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Unilife- Seeking Alpha http://bit.ly/5BnUlW
  12. Novartis Looks at Combination Pills to Fix Hypertension Franchise- BNET Pharma http://bit.ly/6lSOdx
  13. Merger distracts Pfizer from biotech incubator- Fierce Biotech http://bit.ly/4T5vKU
  14. Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate- Seeking Alpha http://bit.ly/8nCc0x
  15. Incyte to license 2 hematology drugs to Novartis- Marketwatch http://bit.ly/8B4EtI
  16. The Vytorin Limbo: How Low Can You Go?- Pharmalot http://bit.ly/62JXIl
  17. Health-Care Bill May Be Stalled by Year-End Legislative Crunch- Bloomberg http://bit.ly/5oSDfJ
  18. Vaccine Makers Struggle to Speed Output- WSJ Online http://bit.ly/8I23NZ
  19. Pfizer's Kindler advises executive soul-searching- Fierce Pharma http://bit.ly/7yMid3
  20. Pfizer takes aim in patent row- FT.com http://bit.ly/6ps4GW